Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.8700 (2.2%) ($34.8700 - $34.8700) on Mon. Jun. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 59 | Latest Price | $34.8700(2.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO advances 1.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(32%) IBB(29%) IWO(29%) EWJ(28%) IWM(28%) | Factors Impacting HALO price | HALO will decline at least -1.385% in a week (0% probabilities). UUP(-22%) TBT(-20%) EDOC(-12%) INDA(-9%) IGOV(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.1(-0.66%) | 10 Day Moving Average | $34.67(0.58%) | 20 Day Moving Average | $34.08(2.32%) | To recent high | -9.8% | To recent low | 15.6% | Market Cap | $4.766b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |